{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:58:20Z","timestamp":1776715100084,"version":"3.51.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00133","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T13:50:03Z","timestamp":1587390603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease"],"prefix":"10.3389","volume":"7","author":[{"given":"Alain","family":"Trautmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugues","family":"Gascan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raouf","family":"Ghozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"B1","unstructured":"2018 Report to Congress, U.S. Department of Health and Human Services"},{"key":"B2","unstructured":"Borreliose de Lyme\n          Surveillance des cas diagnostiqu\u00e9s en m\u00e9decine g\u00e9n\u00e9rale, 2009\u20132018, Sant\u00e9 Publique France"},{"key":"B3","unstructured":"Robert Koch InstituteRKI-Ratgeber2019"},{"key":"B4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2593742","DOI":"10.1155\/2019\/2593742","article-title":"Acetaldehyde induces neurotoxicity in vitro via oxidative stress- and Ca2+ imbalance-mediated endoplasmic reticulum stress","volume":"2019","author":"Cui","year":"2019","journal-title":"Oxid Med Cell Longev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/713609333","article-title":"Acetaldehyde, microbes, and cancer of the digestive tract","volume":"40","author":"Salaspuro","year":"2003","journal-title":"Crit Rev Clin Lab Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/s0006-2952(00)00435-4","article-title":"Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase","volume":"60","author":"Shen","year":"2000","journal-title":"Biochem Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1128\/AAC.00692-15","article-title":"Disulfiram and copper ions kill Mycobacterium tuberculosis in a synergistic manner","volume":"59","author":"Dalecki","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/187152710790966678","article-title":"Disulfiram: an old therapeutic with new applications","volume":"9","author":"Barth","year":"2010","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"B10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/WNF.0000000000000166","article-title":"A case of disulfiram-induced psychosis in a previously asymptomatic patient maintained on mixed amphetamine salts: a review of the literature and possible pathophysiological explanations","volume":"39","author":"Spiegel","year":"2016","journal-title":"Clin Neuropharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/odi.12341","article-title":"Acetaldehyde production by major oral microbes","volume":"21","author":"Moritani","year":"2015","journal-title":"Oral Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/CEJ.0b013e32833d936d","article-title":"Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update","volume":"19","author":"Goldstein","year":"2010","journal-title":"Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP."},{"key":"B13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature."},{"key":"B14","first-page":"1266","article-title":"Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram","volume":"9","author":"Zhang","year":"2019","journal-title":"Am J Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ijc.21534","article-title":"Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram","volume":"118","author":"L\u00f6vborg","year":"2006","journal-title":"Int J Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS-MAPK and NF\u03baB pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Yip","year":"2011","journal-title":"Br J Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/carcin\/bgt366","article-title":"Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage","volume":"35","author":"Paranjpe","year":"2014","journal-title":"Carcinogenesis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1124\/mol.65.3.675","article-title":"The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1)","volume":"65","author":"Sauna","year":"2004","journal-title":"Mol Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3314\/jjmm.48.109","article-title":"Antifungal potential of disulfiram","volume":"48","author":"Khan","year":"2007","journal-title":"Nihon Ishinkin Gakkai Zasshi Jpn J Med Mycol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-011-9200-z","article-title":"Ascorbate and thiol antioxidants abolish sensitivity of yeast Saccharomyces cerevisiae to disulfiram","volume":"28","author":"Kwolek-Mirek","year":"2012","journal-title":"Cell Biol Toxicol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.76.10.5303","article-title":"Tetraethylthiuram disulfide (Antabuse) inhibits the human malaria parasite Plasmodium falciparum","volume":"76","author":"Scheibel","year":"1979","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e00898","DOI":"10.1128\/AAC.00898-17","article-title":"Repurposing thiram and disulfiram as antibacterial agents for multidrug-resistant Staphylococcus aureus infections","volume":"61","author":"Long","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1128\/AAC.02316-13","article-title":"Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus","volume":"58","author":"Haeili","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1128\/AAC.06445-11","article-title":"Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates","volume":"56","author":"Horita","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ijantimicag.2019.03.024","article-title":"Repurposing disulfiram for treatment of Staphylococcus aureus infections","volume":"53","author":"Thakare","year":"2019","journal-title":"Int J Antimicrob Agents."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2147\/DDDT.S101486","article-title":"Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening","volume":"10","author":"Pothineni","year":"2016","journal-title":"Drug Des Devel Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/antibiotics8020072","article-title":"Disulfiram (Tetraethylthiuram Disulfide) in the treatment of lyme disease and babesiosis: report of experience in three cases","volume":"8","author":"Liegner","year":"2019","journal-title":"Antibiot Basel Switz."},{"key":"B28","first-page":"429","article-title":"Disulfiram neuropathy: a review (1971-1988) and report of a case","volume":"24","author":"Frisoni","year":"1989","journal-title":"Alcohol Alcohol Oxf Oxfs."},{"key":"B29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/s0181-5512(06)70114-0","article-title":"Optic neuropathy while taking disulfiram","volume":"29","author":"Bessero","year":"2006","journal-title":"J Fr Ophtalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/S0790966700010454","article-title":"Disulfiram induced peripheral neuropathy: between the devil and the deep blue sea","volume":"24","author":"Behan","year":"2007","journal-title":"Ir J Psychol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4236\/ijcm.2013.47054","article-title":"A case study of gut fermentation syndrome (auto-brewery) with Saccharomyces cerevisiae as the causative organism","volume":"4","author":"Cordell","year":"2013","journal-title":"Int J Clin Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e000325","DOI":"10.1136\/bmjgast-2019-000325","article-title":"Case report and literature review of auto-brewery syndrome: probably an underdiagnosed medical condition","volume":"6","author":"Malik","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.9758\/cpn.2017.15.1.68","article-title":"Disulfiram induced psychosis","volume":"15","author":"Mohapatra","year":"2017","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1460-9568.2008.06425.x","article-title":"Neurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathy","volume":"28","author":"Dina","year":"2008","journal-title":"Eur J Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment lyme syndrome and central sensitization","volume":"25","author":"Batheja","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/aje\/153.6.604","article-title":"Multiple chemical sensitivity and chronic fatigue syndrome in British Gulf War veterans","volume":"153","author":"Reid","year":"2001","journal-title":"Am J Epidemiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1749-6632.2001.tb05828.x","article-title":"Potential mechanisms in chemical intolerance and related conditions","volume":"933","author":"Clauw","year":"2001","journal-title":"Ann N Y Acad Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ejca.2013.11.034","article-title":"Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)","volume":"50","author":"Gravis","year":"2014","journal-title":"Eur J Cancer Oxf Engl."},{"key":"B39","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T13:50:07Z","timestamp":1587390607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":39,"alternative-id":["10.3389\/fmed.2020.00133"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00133","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"article-number":"133"}}